JPH05501062A - Ｈｉｖ―１のウイルス性コンプレックス抗原に結合する組換え蛋白質 - Google Patents

Ｈｉｖ―１のウイルス性コンプレックス抗原に結合する組換え蛋白質

Info

Publication number
JPH05501062A
JPH05501062A JP3509464A JP50946491A JPH05501062A JP H05501062 A JPH05501062 A JP H05501062A JP 3509464 A JP3509464 A JP 3509464A JP 50946491 A JP50946491 A JP 50946491A JP H05501062 A JPH05501062 A JP H05501062A
Authority
JP
Japan
Prior art keywords
protein
sc3d6
chain
antibody
recombinant protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3509464A
Other languages
English (en)
Japanese (ja)
Inventor
ユングバウエル・アロイス
カティンゲル・ヘルマン
リューケル・フローリアン
フエルゲンハウエル・マルティン
ヒンムレル・ゴットフリート
コール・ヨハン
シュタインドル・フランツ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPH05501062A publication Critical patent/JPH05501062A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP3509464A 1990-05-29 1991-05-28 Ｈｉｖ―１のウイルス性コンプレックス抗原に結合する組換え蛋白質 Pending JPH05501062A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0117890A AT396939B (de) 1990-05-29 1990-05-29 Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
AT1178/90 1990-05-29

Publications (1)

Publication Number Publication Date
JPH05501062A true JPH05501062A (ja) 1993-03-04

Family

ID=3508299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3509464A Pending JPH05501062A (ja) 1990-05-29 1991-05-28 Ｈｉｖ―１のウイルス性コンプレックス抗原に結合する組換え蛋白質

Country Status (7)

Country Link
EP (1) EP0484500A1 (de)
JP (1) JPH05501062A (de)
AT (1) AT396939B (de)
CA (1) CA2064710A1 (de)
SK (1) SK160391A3 (de)
WO (1) WO1991018983A1 (de)
YU (1) YU114691A (de)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026895A1 (fr) * 1993-05-10 1994-11-24 Japan Tobacco Inc. Gene vh d'immunoglobuline humaine et fragment d'adn contenant ce gene
US6096878A (en) * 1993-05-10 2000-08-01 Japan Tobacco Inc. Human immunoglobulin VH gene segments and DNA fragments containing the same
US6936705B1 (en) 1993-05-10 2005-08-30 Japan Tobacco Inc. Human immunoglobulin VH gene segments and DNA fragments containing the same
JP2008542278A (ja) * 2005-05-27 2008-11-27 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｔｗｅａｋ結合抗体
US8440189B2 (en) 1999-01-15 2013-05-14 Biogen Idec Ma Inc. Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
US9011859B2 (en) 2002-04-09 2015-04-21 Biogen Idec Ma Inc. Methods for treating TWEAK-related conditions
US9730947B2 (en) 2005-06-13 2017-08-15 Biogen Ma Inc. Method of treating lupus nephritis
US9775899B2 (en) 2005-02-17 2017-10-03 Biogen Ma Inc. Treating neurological disorders

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110295A1 (en) * 1992-03-30 1993-10-14 Tatsuya Kurihara Anti-hbs antibody genes and expression plasmids therefor
CA2402729A1 (en) * 2000-03-15 2001-09-20 Incyte Genomics, Inc. Human immune response proteins
WO2006122187A2 (en) 2005-05-10 2006-11-16 Biogen Idec Ma Inc. Treating and evaluating inflammatory disorders
JP2010528583A (ja) * 2007-06-11 2010-08-26 エーシー イミューン ソシエテ アノニム アミロイドβに対するヒト化抗体
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
PL2238166T3 (pl) 2007-10-05 2014-07-31 Genentech Inc Zastosowanie przeciwciała anty-Beta amyloidowego w chorobach oczu
EP2282769A4 (de) 2008-04-29 2012-04-25 Abbott Lab Dual-variable- domain-immunglobuline und ihre verwendungen
KR20110016959A (ko) 2008-06-03 2011-02-18 아보트 러보러터리즈 이원 가변 도메인 면역글로불린 및 이의 용도
MX2012002651A (es) 2009-09-01 2012-05-22 Abbott Lab Inmunoglobulinas de dominio variable doble y usos de las mismas.
AR078651A1 (es) 2009-10-15 2011-11-23 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
UY32979A (es) 2009-10-28 2011-02-28 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
US9221900B2 (en) 2010-07-30 2015-12-29 Ac Immune S.A. Methods for identifying safe and functional humanized antibodies
KR20130100118A (ko) 2010-08-03 2013-09-09 아비에 인코포레이티드 이원 가변 도메인 면역글로불린 및 이의 용도
US9046513B2 (en) 2010-08-26 2015-06-02 Abbvie Inc. Dual variable domain immunoglobulins and uses thereof
AR089529A1 (es) 2011-12-30 2014-08-27 Abbvie Inc Proteinas de union especificas duales dirigidas contra il-13 y/o il-17
PE20151179A1 (es) 2012-11-01 2015-09-12 Abbvie Inc Inmunoglobulinas de dominio variable dual anti-vegf/dll4 y usos de las mismas
AU2014227732A1 (en) 2013-03-15 2015-09-17 Abbvie Inc. Dual specific binding proteins directed against IL-1 beta and IL-17
US10093733B2 (en) 2014-12-11 2018-10-09 Abbvie Inc. LRP-8 binding dual variable domain immunoglobulin proteins
TW201710286A (zh) 2015-06-15 2017-03-16 艾伯維有限公司 抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851341A (en) * 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system
NZ226414A (en) * 1987-10-02 1992-07-28 Genentech Inc Cd4 peptide adhesion variants and their preparation and use
EP0312164A1 (de) * 1987-10-16 1989-04-19 Merck & Co. Inc. Reinigung von rekombinanten Epstein-Barr-Virusantigenen von Vero-, Hefe- oder L-Zellen
ATE135743T1 (de) * 1987-11-13 1996-04-15 Hermann Katinger Monoklonale menschliche antikörper gegen hiv-i

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026895A1 (fr) * 1993-05-10 1994-11-24 Japan Tobacco Inc. Gene vh d'immunoglobuline humaine et fragment d'adn contenant ce gene
US6096878A (en) * 1993-05-10 2000-08-01 Japan Tobacco Inc. Human immunoglobulin VH gene segments and DNA fragments containing the same
US6936705B1 (en) 1993-05-10 2005-08-30 Japan Tobacco Inc. Human immunoglobulin VH gene segments and DNA fragments containing the same
US8440189B2 (en) 1999-01-15 2013-05-14 Biogen Idec Ma Inc. Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
US9011859B2 (en) 2002-04-09 2015-04-21 Biogen Idec Ma Inc. Methods for treating TWEAK-related conditions
US9775899B2 (en) 2005-02-17 2017-10-03 Biogen Ma Inc. Treating neurological disorders
JP2008542278A (ja) * 2005-05-27 2008-11-27 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｔｗｅａｋ結合抗体
JP2017025105A (ja) * 2005-05-27 2017-02-02 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． Ｔｗｅａｋ結合抗体
US9730947B2 (en) 2005-06-13 2017-08-15 Biogen Ma Inc. Method of treating lupus nephritis

Also Published As

Publication number Publication date
SK160391A3 (en) 1995-07-11
CA2064710A1 (en) 1991-11-30
ATA117890A (de) 1993-05-15
WO1991018983A1 (de) 1991-12-12
AT396939B (de) 1993-12-27
EP0484500A1 (de) 1992-05-13
YU114691A (sh) 1994-06-10

Similar Documents

Publication Publication Date Title
ES2334184T3 (es) Metodo de identificacion de dominios de sitios de union que conservan la capacidad de unirse a un epitopo.
JP4386741B2 (ja) ｓｃＤｂライブラリーの作成方法
EP0894135B1 (de) Multivalentes und multispezifisches antigenbindungs protein
RU2744274C1 (ru) Моноклональное антитело к RBD фрагменту в составе S белка вируса SARS-CoV-2
AT396939B (de) Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
AU657788B2 (en) Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
JP2018510623A (ja) Ｎｋｇ２ｄ及び腫瘍関連抗原に対する二価抗体
WO2000020460A1 (en) Methods for producing human tumor antigen specific antibodies
JP2004537952A (ja) 多重特異的結合分子とその使用
WO1996019584A1 (en) Chimeric antibodies comprising antigen binding sites and b and t cell epitopes
JP2007231027A (ja) 癌マーカー用生物合成結合蛋白質
Kurucz et al. A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor.
KR20210143097A (ko) Cd22에 특이적인 항체 및 이의 용도
KR102453605B1 (ko) 신규 펩타이드 태그, 이에 결합하는 항체 및 이들의 용도
JPH11510375A (ja) ペプチド−ｍｈｃ複合体を指向するファージディスプレイライブラリーからの組換え抗体
KR20210143096A (ko) Cd22에 특이적인 항체 및 이의 용도
JP2000508881A (ja) 免疫グロブリン遺伝子の再編成されたゲノム可変領域のｐｃｒ増幅
EP1033406A1 (de) Induktor zur herstellung antigen-spezifischer antikörper, expressionsvektor enthaltend ein hierfür entsprechendes gen, sowie verfahren zur induktion der herstellung eines antigen-spezifischen antikörpers
KR102829757B1 (ko) 인간화된 cd22에 특이적인 항체 및 이를 이용한 키메라 항원 수용체
KR20220122844A (ko) Cd22에 특이적인 인간화 항체 및 이의 용도
KR20150002588A (ko) 인터페론 및 면역글로불린 fc 섹션 융합 단백질
KR100467706B1 (ko) Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체
CN113683692A (zh) SARS-CoV-2 N蛋白抗体及其应用
CN120518757B (zh) 一种聚乙二醇化多价抗西尼罗病毒单链抗体
WO2006041211A1 (ja) 可塑剤に対する結合能を有する蛋白質